Michael Maitland, MD, PhD, Named Director of Therapeutics for the Inova Center for Personalized Health



Michael Maitland, MD, PhD

Michael Maitland, MD, PhD

Inova Health System is pleased to welcome Michael Maitland, MD, PhD, where he will serve as the new Director of Therapeutics for the Inova Center for Personalized Health and as Associate Director of Cancer Therapeutics for the Inova Schar Cancer Institute. 

Dr. Maitland comes to Inova from the University of Chicago, where he was the Co-Leader of the Cancer Developmental Therapeutics Program, Assistant Director of the Center for Personalized Therapeutics, and Assistant Professor of Medicine in the Section of Hematology/Oncology and the Committee on Clinical Pharmacology and Pharmacogenomics. He brings broad expertise to Inova in human genetics; drug development; cardiovascular safety of new cancer drugs; clinical pharmacology consultations; and care of cancer patients with advanced metastatic disease.

Focus on Personalized Therapy

“Dr. Maitland is a strong addition to the team, bringing substantial expertise in translational medicine and therapeutics research to develop improved methods of personalized therapy,” said Donald L. ‘Skip’ Trump, MD, FACP, CEO, Inova Schar Cancer Institute.

Dr. Maitland will work closely with Inova investigators, University partners, and regional and national biotechnology and pharmaceutical collaborators to ensure quality and value in clinical therapeutics science. He is evaluating the development of new biomarkers to better personalize treatments as “adaptive, responsive therapy.”

Dr. Maitland earned his MS and PhD in microbiology and immunology, as well as his medical degree, at the Albert Einstein College of Yeshiva University. Dr. Maitland completed his internal medicine residency at the New York Presbyterian Hospital/Weill Cornell Medical Center. Subsequently, he worked as a Fellow in Medical Oncology at Memorial Sloan Kettering Cancer Center in New York before completing a joint fellowship in medical oncology and clinical pharmacology and pharmacogenomics at the University of Chicago.

Inova is a not-for-profit health-care system based in Northern Virginia that serves more than 2 million people each year throughout the Washington, DC, metro area and beyond. Inova is a comprehensive network of hospitals; outpatient services and facilities; primary and specialty care practices; and health and wellness initiatives. ■



Advertisement

Advertisement



Advertisement

click me